Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,517,463
  • Shares Outstanding, K 119,100
  • Annual Sales, $ 99,380 K
  • Annual Income, $ -167,210 K
  • 36-Month Beta 0.73
  • Price/Sales 47.52
  • Price/Cash Flow 0.00
  • Price/Book 8.73

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.86 +12.02%
on 06/28/17
42.18 -10.08%
on 07/26/17
+3.84 (+11.26%)
since 06/27/17
3-Month
29.45 +28.79%
on 05/18/17
42.18 -10.08%
on 07/26/17
+7.79 (+25.85%)
since 04/27/17
52-Week
13.05 +190.65%
on 01/03/17
42.18 -10.08%
on 07/26/17
+21.11 (+125.51%)
since 07/27/16

Most Recent Stories

More News
Exact Sciences Corporation (EXAS) Jumps: Stock Rises 6.2%

Exact Sciences Corporation (EXAS) was a big mover last session, as the company saw its shares rise nearly 6% on the day after the company delivered yet another quarter of greater than 100% top-line growth....

AGEN : 4.48 (-14.83%)
EXAS : 37.93 (-4.34%)
Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $57.6 million and completed approximately 135,000 Cologuard tests during the quarter ended June 30, 2017. Second-quarter...

EXAS : 37.93 (-4.34%)
Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?

ImmunoGen has made significant progress with its ovarian cancer pipeline candidate. Let's see if the company can come up with a beat this earnings season.

EXAS : 37.93 (-4.34%)
IMGN : 6.09 (-1.62%)
NVLS : 2.40 (+2.13%)
RHHBY : 31.6100 (-0.16%)
Why Exact Sciences (EXAS) Might Surprise This Earnings Season

Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

EXAS : 37.93 (-4.34%)
New Strong Buy Stocks for July 19th

New Strong Buy Stocks for July 19th

A : 59.91 (+0.32%)
EXAS : 37.93 (-4.34%)
CI : 172.07 (-0.86%)
CUNB : 37.05 (unch)
FUN : 68.98 (-0.71%)
New Strong Buy Stocks for July 17th

New Strong Buy Stocks for July 17th

EXAS : 37.93 (-4.34%)
FOXF : 38.40 (+0.92%)
BANF : 106.10 (-0.66%)
BWP : 17.36 (+0.06%)
FUN : 68.98 (-0.71%)
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

ENZ : 10.97 (-2.83%)
ALIM : 1.46 (+0.69%)
SRPT : 40.58 (-4.38%)
EXAS : 37.93 (-4.34%)
VRTX : 156.19 (-4.42%)
5 Top Multibagger Biotech Stocks to Buy in the 2nd Half

Draconian crackdown on drug prices easing out and likelihood of a series of buyouts will help innovation starved biotech companies to gain in the second half.

ENZ : 10.97 (-2.83%)
ALIM : 1.46 (+0.69%)
CELG : 134.15 (-2.61%)
EXAS : 37.93 (-4.34%)
SRPT : 40.58 (-4.38%)
VRTX : 156.19 (-4.42%)
REGN : 508.41 (-1.40%)
KITE : 108.88 (-2.12%)
ALXN : 133.92 (+2.17%)
Today's Research Reports on Stocks to Watch: BioCryst Pharmaceuticals and Exact Sciences

NEW YORK, NY / ACCESSWIRE / July 7, 2017 / U.S. markets continued to be dragged down by a selloff in technology stocks. The Dow Jones Industrial Average declined 0.74 percent to close at 21,320.04, while...

EXAS : 37.93 (-4.34%)
BCRX : 5.10 (+1.39%)
Technical Snapshots for These Medical Laboratories Stocks -- Exact Sciences, HTG Molecular Diagnostics, TrovaGene, and Novadaq Technologies

If you want a Stock Review on EXAS, HTGM, TROV or NVDQ then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Ahead of today's trading session, DailyStockTracker.com...

NVDQ : 11.68 (-0.43%)
TROV : 0.94 (+4.44%)
HTGM : 2.39 (-3.24%)
EXAS : 37.93 (-4.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Support & Resistance

2nd Resistance Point 41.95
1st Resistance Point 39.94
Last Price 37.93
1st Support Level 36.22
2nd Support Level 34.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.